Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: S194198. doi: 10.1684/mrh.2010.0213.
Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr 2013; 4: 378S-83S. doi: 3945/an.112.003483.
Xue W, You J, Su Y, Wang Q. The effect of magnesium deficiency on neurological disorders: a narrative review article. Iran J Public Health 2019; 48: 379-87.
Poenaru S, Manicom R, Rouhani S, et al. Stability of brain content of magnesium in experimental hypomagnesemia. Brain Res 1997; 769: 329-32.
Durlach J, Bac P, Durlach V, Rayssiguier Y, Bara M, Guiet-Bara A. Magnesium status and ageing: an update. Magnes Res 1998; 11: 25-42.
Muller RU, Finkelstein A. The electrostatic basis of Mg + + inhibition of transmitter release. Proc Natl Acad Sci 1974; 71: 923-6.
Magnusson KR. Declines in mRNA expression of different subunits may account for differential effects of aging on agonist and antagonist binding to the NMDA receptor. J Neurosci 2000; 20: 1666-74.
Billard JM. Ageing, hippocampal synaptic activity and magnesium. Magnes Res 2006; 19: 199-215.
Billard J-M. Brain magnesium homeostasis as a target for reducing cognitive ageing. In: Vink R, Nechifor M, (eds). Magnesium in the central nervous system. Adelaide: University of Adelaide Press;99-112. ISBN 978-0-9870730-5-1.
Bardgett ME, Schultheis PJ, McGill DL, Richmond RE, Wagge JR. Magnesium deficiency impairs fear conditioning in mice. Brain Res 2005; 1038: 100-6.
Landfield PW, Morgan GA. Chronically elevating plasma Mg2+ improves hippocampal frequency potentiation and reversal learning in aged and young rats. Brain Res 1984; 322: 167-71.
Li W, Yu J, Liu Y, et al. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model. Mol Brain 2014; 7: 65.
Slutsky I, Abumaria N, Wu L-J, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron 2010; 65: 165-77.
Chui D, Chen Z, Yu J, et al. Magnesium in Alzheimer’s disease. In: Vink R, Nechifor M, (eds). Magnesium in the central nervous system. Adelaide: University of Adelaide Press.
Bac P, Herrenknecht C, Binet P, Durlach J. Audiogenic seizures in magnesium-deficient mice: effects of magnesium pyrrolidone-2-carboxylate, magnesium acetyltaurinate, magnesium chloride and vitamin B-6. Magnes Res 1993; 6: 11-9.
Bac P, Herrenknecht C, Pagès N, Dupont C, Durlach J. Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium-deficient rats: I-Comparative study of various magnesium salts. Magnes Res 1996; 9: 281-91.
Jafri AJA, Agarwal R, Lezhitsa I, et al. Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress. Mol Vis 2018; 24: 495-508.
Lambuk L, Jafri AJA, Arfuzir NNN, et al. Neuroprotective effect of magnesium acetyltaurate against NMDA-induced excitotoxicity in rat retina. Neurotox Res 2017; 31: 31-45.
Squire LR. Memory and brain. New York: Oxford University Press. ISBN 978-0-19-504208-5.
Akhondzadeh S. Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther. 1999; 24: 241-8.
Le Roux N, Amar M, Moreau A, Fossier P. Involvement of NR2A-or NR2B-containing NMethyl-D-Aspartate receptors in the potentiation of cortical layer 5 pyramidal neurone inputs depends on the developmental stage. Eur J Neurosci 2007; 26: 289-301.
Tang Y-P, Shimizu E, Dube GR, et al. Genetic enhancement of learning and memory in mice. Nature 1999; 401: 63-9.
Fox CJ, Russell KI, Wang YT, Christie BR. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo. Hippocampus 2006; 16: 907-15.
Villers A, Ris L. Improved preparation and preservation of hippocampal mouse slices for a very stable and reproducible recording of longterm potentiation. J Vis Exp 2013; 26(76): 50483. doi: 10.3791/50483.
Huang Y, Huang X, Zhang L, et al. Magnesium boosts the memory restorative effect of environmental enrichment in Alzheimer’s disease mice. CNS Neurosci Ther 2018; 24: 70-9.
Sun Q, Weinger JG, Mao F, Liu G. Regulation of structural and functional synapse density by Lthreonate through modulation of intraneuronal magnesium concentration. Neuropharmacology 2016; 108: 426-39.
Bagatela BS, Lopes IP, Cruz do Amaral Pupo I, Lopes JC, Gu J, Lopes AP. Biochemical and hematological study of the supplementation with ATAMg, a new source of N-Acetyl-Based organic magnesium, on Bioavailability. HealthMED 2018; 12(4): 187-9.
Uysal N, Kizildag S, Yuce Z, et al. Timeline (Bioavailability) of magnesium compounds in hours: which magnesium compound works best? Biol Trace ElemRes 2019; 187: 128-36.
Ates M, Kizildag S, Yuksel O, et al. Dose-dependent absorption profile of different magnesium compounds. Biol Trace Elem Res 2019; 192: 244-51.
Hosgorler F, Koc B, Kizildag S, et al. Magnesium acetyl taurate prevents tissue damage and deterioration of prosocial behavior related with vasopressin levels in traumatic brain injured rats. Turk Neurosurg 2020; 30(5): 723-33.
Slutsky I, Sadeghpour S, Li B, Liu G. Enhancement of synaptic plasticity through chronically reduced Ca2+ flux during uncorrelated activity. Neuron 2004; 44: 835-49.
Magnusson KR, Brim BL, Das SR. Selective vulnerabilities of N-Methyl-D-Aspartate (NMDA) receptors during brain aging. Front Aging Neurosci 2010; 2: 11.
